Since taking over as FDA commissioner in May, Scott Gottlieb has moved forward at a ferocious pace in rolling out new major initiatives and advancing policy developments that will have significant impacts on product-makers and patients alike.
Gottlieb spoke Nov. 3 before National Press Club in Washington, D.C. (Also see "Five Takeaways From Commissioner Gottlieb's Talk...